Literature DB >> 2027124

The use of radiographs in assessing the severity of knee osteoarthritis.

T D Spector1, D J Hart, E C Huskisson.   

Abstract

Conventional radiographic grading of the knee has been used for 30 years and is based around the presence of osteophytes. About 50% of subjects from the general population meeting traditional radiographic criteria are asymptomatic or have no signs of clinical disease. Recent development in the use of different radiographic grading systems involve more attention to joint space and categorization of discrete radiographic findings. These techniques include new grading scales that use a combination of separate radiographic features; microfocal radiography and digitized image analysis of joint space. It is hoped these might reflect more closely the pathological processes and correlate more closely with clinical severity.

Entities:  

Mesh:

Year:  1991        PMID: 2027124

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  3 in total

1.  Irregularity of medial femoral condyle on MR imaging serves as a possible indicator of objective severity of medial-type osteoarthritic knee-a pilot study.

Authors:  Junichi Iwasaki; Takahisa Sasho; Koichi Nakagawa; Shuhei Ogino; Nobuyasu Ochiai; Hideshige Moriya
Journal:  Clin Rheumatol       Date:  2007-02-24       Impact factor: 2.980

2.  Predictive factors for new onset or progression of knee osteoarthritis one year after trauma: MRI follow-up in general practice.

Authors:  Ingrid M Koster; Edwin H G Oei; Jan-Hein J Hensen; Simone S Boks; Bart W Koes; Dammis Vroegindeweij; M G Myriam Hunink; Sita M A Bierma-Zeinstra
Journal:  Eur Radiol       Date:  2011-03-06       Impact factor: 5.315

3.  Evaluation of a multimodal pain therapy concept for chronic pain after total knee arthroplasty: a pilot study in 21 patients.

Authors:  Dirk Zajonz; Johannes K M Fakler; Anna-Judith Dahse; Fujiaoshou Junping Zhao; Melanie Edel; Christoph Josten; Andreas Roth
Journal:  Patient Saf Surg       Date:  2017-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.